Literature DB >> 18938777

Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet.

Maiana Verdelho Machado1, Paula Ravasco, Lia Jesus, Pedro Marques-Vidal, Catarina R Oliveira, Teresa Proença, Inês Baldeiras, Maria Ermelinda Camilo, Helena Cortez-Pinto.   

Abstract

OBJECTIVE: Non-alcoholic fatty liver disease is a common condition that can progress to endstage liver disease. The steatotic liver seems to be particularly susceptible to oxidative stress damage. The aim of this study was to evaluate the redox state in patients with non-alcoholic steatohepatitis (NASH) and its correlation with dietary intake.
MATERIAL AND METHODS: Plasma concentrations of 4-hydroxynonenal (4-HNE), 8-hydroxydeoxyguanosine (8-OHdG), reduced and oxidized glutathione (GSH and GSSG), vitamins A and E, total antioxidant status (TAS), glutathione peroxidase (GSH-Px) and reductase (GSH-Red) erythrocyte activities were compared between 43 NASH patients and 33 healthy controls. 4-HNE, GSH-Px, GSH-Red and TAS were evaluated by spectrophotometry, 8-OHdG by ELISA assay, GSH and GSSG by fluorimetric assay and vitamins A and E by high performance liquid chromatography. Dietary habits were also evaluated in these patients.
RESULTS: GSH levels (21.1 +/- 18.3 versus 33.1 +/- 22.2 microM, p = 0.01) and GSH/GSSG ratio (0.9 +/- 0.7 versus 1.5 +/- 0.8, p = 0.01) were lower and TAS (832 +/- 146 versus 630 +/-140 microM, p < 0.001) and vitamin E (47.1 +/- 14.9 versus 34.5 +/- 7.3 microM, p < 0.001) were higher in NASH patients, although there was no difference in GSH-Px and GSH-Red activities, 8-OHdG and 4-HNE levels between groups. After adjusting for total energy consumption, a negative correlation was found with total and saturated fat intake and GSH/GSSG ratio, and a positive correlation with carbohydrates, fiber, monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), specifically N-3 PUFA, and vitamins E, C, selenium and folate.
CONCLUSIONS: Our data suggest an impaired glutathione metabolism towards an oxidant status in NASH patients, correlating with a higher intake of saturated fat and a lower intake of carbohydrates. Plasmatic concentrations of oxidative stress cellular markers did not translate to hepatic oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938777     DOI: 10.1080/00365520701559003

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  25 in total

Review 1.  Nutrition and nonalcoholic fatty liver disease in children.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2008-06

2.  Nutrition and nonalcoholic fatty liver disease in children.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

Review 3.  Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries.

Authors:  Hilmar K Lückhoff; Frederik C Kruger; Maritha J Kotze
Journal:  World J Hepatol       Date:  2015-05-28

4.  A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits.

Authors:  Tomohiro Ogawa; Hideki Fujii; Katsutoshi Yoshizato; Norifumi Kawada
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 5.  Role of xenobiotics in the induction and progression of fatty liver disease.

Authors:  James E Klaunig; Xilin Li; Zemin Wang
Journal:  Toxicol Res (Camb)       Date:  2018-05-18       Impact factor: 3.524

6.  Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis.

Authors:  Amit Kumar; Arun Sharma; Ajay Duseja; Ashim Das; Radha K Dhiman; Yogesh K Chawla; Krishan K Kohli; Anil Bhansali
Journal:  J Clin Exp Hepatol       Date:  2012-11-02

7.  Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Yu Yang; Arthur J McCullough; Susan Marczewski; Carole Bennett; Satish C Kalhan
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-05       Impact factor: 2.566

Review 8.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 9.  Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.

Authors:  Shira Zelber-Sagi; Vlad Ratziu; Ran Oren
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

10.  Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis.

Authors:  Man-Jie Zhu; Li-Juan Sun; Yue-Qin Liu; Yan-Ling Feng; Hai-Tao Tong; Ying-He Hu; Zheng Zhao
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.